Mr. Speaker, I thank my hon. colleague for his question.
I have a great deal of respect for Quebec researchers and for the lab in question because I have visited it before. To set the record straight, we did not invest $2 million in Medicago; we invested $173 million. We also invested in Biodextris in Laval, Glycovax Pharma in Montreal, JN Nova Pharma in Montreal and Laurent Pharmaceuticals in Montreal.
We made critical investments for the industry and we will continue to invest in the research and development and the marketing of vaccines in Canada.